Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DTP0 | ISIN: GG00BP6KMG85 | Ticker-Symbol: N/A
1-Jahres-Chart  (nicht börsennotiert)
GOODBODY HEALTH LIMITED Chart 1 Jahr
Dow Jones News
638 Leser
Artikel bewerten:
(2)

J P Jenkins Ltd: Goodbody Health Limited - Matched Bargain Dealing Facility

DJ J P Jenkins Ltd: Goodbody Health Limited - Matched Bargain Dealing Facility

J P Jenkins Ltd J P Jenkins Ltd: Goodbody Health Limited - Matched Bargain Dealing Facility 16-May-2023 / 07:30 GMT/BST The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

16th May 2023

JPJ:GDBY

0002

Goodbody Health Limited

Matched Bargain Dealing Facility

16th May 2023 - Shares in Goodbody Health Limited have been admitted to trade on JP Jenkins share dealing platform. Goodbody Health Limited is based at Blue Building Stubbs Lane, Beckington, Frome, Somerset, United Kingdom, BA11 6TE and is registered as a company in England and Wales under Companies House, company number 12427077.

Goodbody Health is an established health and wellness company that operates within the United Kingdom and Europe as a trusted aggregator, distributor and retailer of quality, accredited wellness products and diagnostic services to provides a unique 'frontline' healthcare service in the local community and enable customers to manage their health care digitally. It operates under the mantra 'Know More. Live Better' to provide healthcare testing services in the local community.

JP Jenkins is the longest established trading platform in UK for unlisted or unquoted companies, enabling shareholders and prospective investors to transact on a matched bargain basis.?

Should shareholders wish to trade their shares they can do so through their stockbroker. The indicative price and transaction history are available on JP Jenkins's website: https://jpjenkins.com/company/ goodbody-health-limited-coming-soon/.

George Thomas, CEO of Goodbody Health Limited said: "Delighted to be joining JP Jenkins, to offer their share matching services to existing shareholders, and I look forward to welcoming new investors as we continue to focus on growth."

Veronika Oswald, Commercial Director of J P Jenkins said: "Lovely to see another company joining the established JP Jenkins share dealing platform as we continue to grow our innovative and technology enhanced venue for private companies."

For further information, please contact:

J P Jenkins Ltd. 
Veronika Oswald 
             +44 (0)20 7469 0937 
Commercial Director 
 
Goodbody Health Limited 
George Thomas 
CEO           +44 (0) 1373 486595 
 

-----------------------------------------------------------------------------------------------------------------------

Dissemination of a CORPORATE NEWS, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

End of Announcement - EQS News Service

1633583 16-May-2023

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1633583&application_name=news

(END) Dow Jones Newswires

May 16, 2023 02:30 ET (06:30 GMT)

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2023 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.